Chugai Pharma USA, Inc. (CPUSA) is a wholly owned subsidiary of Chugai Pharmaceutical Co., Ltd. It handles clinical development, regulatory affairs, and partnering for Chugai's pharmaceutical products in the U.S. Headquartered in Berkeley Heights, New Jersey, with a partnering branch in South San Francisco, California.
Multi-year framework to streamline early-stage target discovery and therapeutic development using antibody engineering, macrocyclic peptides and small-molecule platforms.
